EU-funded computational biology PhD position (Prostate Research)
Education Requirements:
PhD candidate
Other Requirements:
EU-funded
Responsibilities:
Prostate Research
Computational biology
Show more details
Identify new therapeutic indications for existing compounds using an AI-powered systems biology platform to reduce R&D costs and accelerate time-to-market.

Delta4 is a specialized TechBio company that leverages artificial intelligence and systems biology to revolutionize the drug discovery process. Its primary mission is to help pharmaceutical and biotechnology companies expand the indications for drugs that already possess established safety profiles. By focusing on drug repurposing and indication expansion, the platform enables organizations to bypass many of the initial risks associated with early-stage drug development, significantly shortening the timeline for bringing new treatments to patients. This approach focuses on efficiency and safety by building upon clinical data that has already been verified in human subjects. At the core of Delta4’s offering is Hyper-C, a proprietary AI-powered software platform. This technology integrates large-scale biological data with computational modeling to simulate and predict drug behavior in silico. The platform is operated by a dedicated team of computational biologists who analyze complex disease mechanisms and detect previously undetected relationships between known drugs and potential new therapeutic targets. This data-driven approach allows for high precision and speed in uncovering new opportunities that traditional lab-based methods might overlook, making it possible to identify potential treatments for complex conditions like Long COVID. The service is specifically designed for R&D teams in the pharmaceutical industry, academic research institutions, and biotech startups. By providing detailed in-silico models and predictive insights, Delta4 helps these stakeholders reduce the high costs and failure rates typically associated with clinical trials. The tool is particularly effective for organizations looking to breathe new life into existing assets or those focused on specialized areas where understanding intricate biological networks is crucial for therapeutic success. What distinguishes Delta4 from generic AI discovery tools is its deep integration of systems biology with human expertise. Unlike purely automated solutions, Delta4 emphasizes a collaborative process where AI-generated insights are refined by subject matter experts. Furthermore, its membership in frameworks like Scientist.com ensures a streamlined and transparent collaboration process, making it a reliable partner for global pharmaceutical giants and top-tier medical universities. The company maintains an active presence in the scientific community, regularly publishing research on Proof of Concept clinical trials and innovative drug development strategies.
Delta4 focuses on indication expansion, using its Hyper-C platform to find new therapeutic uses for existing drugs with known safety profiles. This reduces the time and risk associated with traditional drug development.
Hyper-C is a proprietary AI-powered software platform that combines systems biology and computational modeling to predict drug behavior in silico. It allows researchers to detect relationships between drugs and diseases with high accuracy.
The Hyper-C platform is operated by a team of highly skilled computational biologists. They manually analyze the data outputs to produce unique insights and validate drug indication expansion opportunities.
Yes, Delta4 offers collaborations on research, co-development, and consortia projects. They work with pharmaceutical companies, biotech firms, and academic institutions globally.
Delta4 is a member of Scientist.com, which provides a platform for streamlining transparency and cooperation. This framework simplifies the process of defining terms and conditions for agreements.
The platform provides predictive data and in-silico models that help inform and accelerate early Phase II clinical studies. This helps researchers answer fundamental questions about drug efficacy before full-scale trials.
Education Requirements:
PhD candidate
Other Requirements:
EU-funded
Responsibilities:
Prostate Research
Computational biology
Show more details
Education Requirements:
PhD candidate
Other Requirements:
EU-funded
Responsibilities:
Kidney Research
Computational biology
Show more details
No reviews yet. Be the first to share how Delta4 worked for you.